SynthesisBMC musculoskeletal disorders2026
Risk prediction models for postmenopausal osteoporosis: a systematic review and meta-analysis study.
Synthesis in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPostmenopausal osteoporosis usually happens 5 ~ 10 years after menopause. Low awareness, low detection rates and high morbidity have prevented the possibility of early or preventive interventions, thus increasing the social and economic burden on families and societies. A reliable prediction model for postmenopausal osteoporosis has the potential to guide the prevention, but regarding the early prediction of postmenopausal osteoporosis without fracture, this field has not been sufficiently studied. Although many scholars have developed several prediction models to estimate the risk of postmenopausal osteoporosis without fractures, the evidence about the model quality and clinical applicability is scarce.
methodNine databases (Medline, Embase, Web of science, CINAHL, The Cochrane Library, CNKI, SinoMed, Wanfang, VIP data) were systematically searched from 1 January 2014 to 1 May 2024. Two researchers independently extracted data using the CHARMS checklist and assessed bias using the PROBAST tool. The primary outcomes of interest were related to the model’s discriminative ability (assessed by pooled AUC values) and calibration performance (evaluated using calibration curves or the calibration intercept and slope). We performed meta-regression and sensitivity analyses to explore the influence of important factors, such as data sources, machine learning methods, and types of predictor variables, on the aforementioned. results. Additionally, subgroup analyses were conducted based on data sources, machine learning. methods, and types of predictor variables. The study was registered in the PROSPERO database (registration number CRD42024542498).
resultsA total of 8,549 records were initially identified, and 7 studies (comprising 19 models) were ultimately included. All models were developed based on Asian population data. The risk of bias assessment showed: 1 study had a low risk, 1 study had an unclear risk, and 5 studies had a high risk. The sample sizes ranged from 319 to 4,417 participants. The reported AUC of the models ranged from 0.639 to 0.921; however, the vast majority of studies lacked reports on calibration performance. The pooled C-statistic (AUC) was 0.78 (95%CI: 0.73–0.83). Sensitivity analysis yielded robust results (AUC=0.77). Subgroup analysis indicated that models combining demographic and laboratory data demonstrated the best performance (AUC=0.92). Significant publication bias and substantial heterogeneity (I² = 98%) were observed among the studies.
conclusionCurrent machine learning-based prediction models for postmenopausal osteoporosis without fractures, as presented in the included studies, demonstrate good discriminative ability but are generally characterized by a high risk of bias, a notable lack of calibration performance evaluation, and insufficient validation of clinical utility. Furthermore, existing models are developed entirely on Asian population data, which limits their generalizability to other populations. Future research should focus on strictly adhering to prediction model research guidelines (such as PROBAST), enhancing the reporting of model calibration and clinical utility, and assessing model generalizability through external validation in multi-center studies encompassing diverse ethnicities and regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.